Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
BS Medicine Episode #621: Whole-Body MRI for Cancer Screening: Many findings, little benefit
BS Medicine Episode #620: Back on the stand: Colchicine for secondary cardiovascular prevention update
In the Clinic Episode 58: Neck Pain
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk








Please provide any additional comments (optional).